568 related articles for article (PubMed ID: 23999580)
21. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
Jarius S; Probst C; Borowski K; Franciotta D; Wildemann B; Stoecker W; Wandinger KP
J Neurol Sci; 2010 Apr; 291(1-2):52-6. PubMed ID: 20117794
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis.
Kim SH; Kim SM; Vincent A; Ahn SW; Hong YH; Park KS; Sung JJ; Lee KW
J Neurol; 2010 Jun; 257(6):920-5. PubMed ID: 20049472
[TBL] [Abstract][Full Text] [Related]
23. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
[TBL] [Abstract][Full Text] [Related]
25. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Höftberger R; Sepulveda M; Armangue T; Blanco Y; Rostásy K; Calvo AC; Olascoaga J; Ramió-Torrentà L; Reindl M; Benito-León J; Casanova B; Arrambide G; Sabater L; Graus F; Dalmau J; Saiz A
Mult Scler; 2015 Jun; 21(7):866-874. PubMed ID: 25344373
[TBL] [Abstract][Full Text] [Related]
27. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.
Jarius S; Wildemann B
Brain Pathol; 2013 Nov; 23(6):661-83. PubMed ID: 24118483
[TBL] [Abstract][Full Text] [Related]
28. Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.
Asgari N; Skejoe HP; Lillevang ST; Steenstrup T; Stenager E; Kyvik KO
BMC Neurol; 2013 Apr; 13():33. PubMed ID: 23566260
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
[TBL] [Abstract][Full Text] [Related]
30. Longitudinally extensive transverse myelitis.
Tobin WO; Weinshenker BG; Lucchinetti CF
Curr Opin Neurol; 2014 Jun; 27(3):279-89. PubMed ID: 24792338
[TBL] [Abstract][Full Text] [Related]
31. Neuromyelitis optica IgG status in acute partial transverse myelitis.
Scott TF; Kassab SL; Pittock SJ
Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
[TBL] [Abstract][Full Text] [Related]
32. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
[TBL] [Abstract][Full Text] [Related]
33. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
[TBL] [Abstract][Full Text] [Related]
34. Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis.
Franciotta D; Zardini E; Caporali R; Piccolo L; Alberici E; Romani A; Bergamaschi R; Marchioni E; Ceroni M; Piccolo G
J Neurol Sci; 2011 Apr; 303(1-2):139-41. PubMed ID: 21296362
[TBL] [Abstract][Full Text] [Related]
35. Longitudinally extensive transverse myelitis in systemic lupus erythematosus: case report and review of the literature.
Nardone R; Fitzgerald RT; Bailey A; Zuccoli G
Clin Neurol Neurosurg; 2015 Feb; 129():57-61. PubMed ID: 25544684
[TBL] [Abstract][Full Text] [Related]
36. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
37. Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
Alvarenga MP; Alvarenga RM; Alvarenga MP; Santos AM; Thuler LC
J Spinal Cord Med; 2012 Jul; 35(4):251-5. PubMed ID: 22925751
[TBL] [Abstract][Full Text] [Related]
38. [NMO spectrum disorders and anti AQP4 antibody].
Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
[TBL] [Abstract][Full Text] [Related]
39. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
[TBL] [Abstract][Full Text] [Related]
40. Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis.
Ogaki K; Hirayama T; Chijiiwa K; Fukae J; Furuya T; Noda K; Fujishima K; Hattori N; Takahashi T; Okuma Y
Neurologist; 2012 Mar; 18(2):76-9. PubMed ID: 22367834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
